Smoking Cessation for Pain
(OK-SNAP IV Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether quitting smoking for four weeks, with financial incentives, can improve markers of chronic pain risk in Native American smokers. It examines whether those who stop smoking experience pain differently from those who continue. Participants must be Native American, smoke more than 10 cigarettes a day, want to quit, and have a smartphone with a data plan. This study is for individuals without chronic pain or certain health conditions. As an unphased trial, it offers a unique opportunity to contribute to understanding the link between smoking cessation and pain management in Native American communities.
Will I have to stop taking my current medications?
Yes, you may need to stop taking certain medications, like pain relievers, antidepressants, or anti-anxiety drugs, as they could interfere with the study.
What prior data suggests that this smoking cessation treatment is safe?
Research has shown that quitting smoking can affect pain levels. People who stop smoking have experienced a 23% reduction in pain within a year. Initially, quitting might make pain feel worse and lower the ability to handle it, meaning more pain might be felt at first, but less pain could occur overall in the long run.
Treatments to help quit smoking, such as varenicline and nicotine lozenges, are generally safe. These treatments have been well-studied and are commonly used to assist people in stopping smoking.
In summary, while quitting smoking might cause some short-term discomfort, evidence suggests it can lead to less pain over time. Current research considers the treatments to help quit safe.12345Why are researchers excited about this trial?
Researchers are excited about this approach to smoking cessation for pain because it explores a new angle on managing pain through behavioral change rather than medication. Unlike standard treatments for pain, which often involve medications like opioids or NSAIDs, this method focuses on quitting smoking to potentially reduce pain levels. This is particularly intriguing because smoking has been linked to increased pain perception, so cessation might offer dual benefits: improving overall health and reducing pain. If successful, this approach could provide a non-pharmacological option for pain management, which can be especially appealing for those looking to avoid the side effects of pain medications.
What evidence suggests that smoking cessation might be an effective treatment for chronic pain risk?
Research shows that quitting smoking can greatly reduce pain for people with long-term pain conditions. One study found that people who quit smoking reported feeling 23% less pain after a year compared to those who continued smoking. Smokers with chronic pain often experience worse pain, sleep, and mood than non-smokers. Additionally, smoking is linked to poorer outcomes in pain treatment programs. These findings suggest that stopping smoking could help improve pain for Native American smokers.16789
Who Is on the Research Team?
Jamie L Rhudy, PhD
Principal Investigator
University of Oklahoma Health Sciences
Are You a Good Fit for This Trial?
This trial is for adult Native American smokers who are interested in quitting smoking. The study aims to see if stopping smoking with the help of financial incentives can reduce chronic pain risk. Specific eligibility criteria details are not provided, but typically include being a certain age and having a history of smoking.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo smoking cessation treatment with financial incentives for 4 weeks
Abstinence Verification
Participants are monitored for 4 weeks of verified smoking abstinence
Follow-up
Participants are monitored for changes in physiological markers of chronic pain risk
What Are the Treatments Tested in This Trial?
Interventions
- Smoking Cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor